ConductScience.org, home

Paper26850595

MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1.

Wu DD and 4 others. Tumour Biol, 2016. Cited by 60 papers, by iCite.

Cite this record

ConductScience Library. MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1. Papers, record 26850595. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26850595

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1.
PubMed
Journal
Tumour Biol
PubMed
Year
2016
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
60
iCite
Relative citation ratio, by iCite
2.45
iCite
Revised in PubMed
2022-03-16
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wu DDDi-di
2Li XSXue-Song
3Meng XNXiao-Na
4Yan JJing
5Zong ZHZhi-Hong

Source PubMed

Download CSV of authors

Topics24

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CystadenocarcinomaMajor topic
MicroRNAsMajor topic
Neoplasm ProteinsMajor topic
Ovarian NeoplasmsMajor topic
RNA, NeoplasmMajor topic
3' Untranslated Regions
ATP Binding Cassette Transporter, Subfamily B
Animals
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Phytogenic
Cell Line, Tumor
Cisplatin
Drug Resistance, Multiple
Drug Resistance, Neoplasm
Female
Heterografts
Humans
Mice
Mice, Nude
Paclitaxel
RNA, Antisense
RNA, Messenger
Random Allocation
Transfection

Source PubMed

Download CSV of topics

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18094074Distinct P-glycoprotein expression in two subclones simultaneously selected from a human colon carcinoma cell line by cis-diamminedichloroplatinum (II).Int J Cancer1993https://conductscience.org/library/papers/8094074PubMed
226182353Abraxane, the Nanoparticle Formulation of Paclitaxel Can Induce Drug Resistance by Up-Regulation of P-gp.PLoS One2015https://conductscience.org/library/papers/26182353PubMed
325311867miR-193a-3p regulates the multi-drug resistance of bladder cancer by targeting the LOXL4 gene and the oxidative stress pathway.Mol Cancer2014https://conductscience.org/library/papers/25311867PubMed
415694393Concentration-dependent collateral sensitivity of cisplatin-resistant gastric cancer cell sublines.Biochem Biophys Res Commun2005https://conductscience.org/library/papers/15694393PubMed
521070600Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia.J Cell Mol Med2011https://conductscience.org/library/papers/21070600PubMed
623178914miR-137 restoration sensitizes multidrug-resistant MCF-7/ADM cells to anticancer agents by targeting YB-1.Acta Biochim Biophys Sin (Shanghai)2013https://conductscience.org/library/papers/23178914PubMed
726136956Avastin® in combination with gemcitabine and cisplatin significantly inhibits tumor angiogenesis and increases the survival rate of human A549 tumor-bearing mice.Exp Ther Med2015https://conductscience.org/library/papers/26136956PubMed
88106143Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.Cancer Res1993https://conductscience.org/library/papers/8106143PubMed
923173671MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.BMC Cancer2012https://conductscience.org/library/papers/23173671PubMed
1015930349Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol).Clin Cancer Res2005https://conductscience.org/library/papers/15930349PubMed
1118668431Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition.Xenobiotica2008https://conductscience.org/library/papers/18668431PubMed
1226055179Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line Therapeutics.Transl Oncol2015https://conductscience.org/library/papers/26055179PubMed
1326323558MiR-873 acts as a novel sensitizer of glioma cells to cisplatin by targeting Bcl-2.Int J Oncol2015https://conductscience.org/library/papers/26323558PubMed
1425670861MicroRNA-873 (miRNA-873) inhibits glioblastoma tumorigenesis and metastasis by suppressing the expression of IGF2BP1.J Biol Chem2015https://conductscience.org/library/papers/25670861PubMed
1523933187The anti-chemoresistant effect and mechanism of MUC1 aptamer-miR-29b chimera in ovarian cancer.Gynecol Oncol2013https://conductscience.org/library/papers/23933187PubMed
1625909324MicroRNA let-7c Inhibits Cell Proliferation and Induces Cell Cycle Arrest by Targeting CDC25A in Human Hepatocellular Carcinoma.PLoS One2015https://conductscience.org/library/papers/25909324PubMed
1721939554MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines.J Ovarian Res2011https://conductscience.org/library/papers/21939554PubMed
1824786846miRNAs for the detection of multidrug resistance: overview and perspectives.Molecules2014https://conductscience.org/library/papers/24786846PubMed
1926396496MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.Drug Des Devel Ther2015https://conductscience.org/library/papers/26396496PubMed
2024645868MicroRNAs and their relevance to ABC transporters.Br J Clin Pharmacol2014https://conductscience.org/library/papers/24645868PubMed

See all 32 referencesDownload CSV of references

Cited by41

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.

PMIDTitleJournalYearIn PapersSource
41964673
The striking divergence of ABCB1 mRNA expression and P-glycoprotein protein levels in M1 and M2 macrophages associates with the microRNA miR-21-3p, a regulator of "RNA binding protein, mRNA processing factor".
Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/41964673PubMed
39808313MiRNAs: main players of cancer drug resistance target ABC transporters.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/39808313PubMed
39185494MicroRNA‑mediated approaches in ovarian cancer therapy: A comprehensive systematic review.Oncol Lett2024https://conductscience.org/library/papers/39185494PubMed
39114709MiR-125b targeted regulation of MKNK2 inhibits multiple myeloma proliferation and invasion.Am J Transl Res2024https://conductscience.org/library/papers/39114709PubMed
38434767Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptors.Cancer Drug Resist2024https://conductscience.org/library/papers/38434767PubMed
36420446Nucleic acid vaccination strategies for ovarian cancer.Front Bioeng Biotechnol2022https://conductscience.org/library/papers/36420446PubMed
35620395The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer.Front Endocrinol (Lausanne)2022https://conductscience.org/library/papers/35620395PubMed
35582723Resistance to cis- and carboplatin initiated by epigenetic changes in ovarian cancer patients.Cancer Drug Resist2019https://conductscience.org/library/papers/35582723PubMed
35582590MicroRNAs and cancer drug resistance: over two thousand characters in search of a role.Cancer Drug Resist2019https://conductscience.org/library/papers/35582590PubMed
35326459MicroRNA as a Potential Therapeutic Molecule in Cancer.Cells2022https://conductscience.org/library/papers/35326459PubMed
34676171MiR-873-5p: A Potential Molecular Marker for Cancer Diagnosis and Prognosis.Front Oncol2021https://conductscience.org/library/papers/34676171PubMed
34593006MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells.J Ovarian Res2021https://conductscience.org/library/papers/34593006PubMed
34512721The Emerging Role of Non-coding RNAs in Drug Resistance of Ovarian Cancer.Front Genet2021https://conductscience.org/library/papers/34512721PubMed
34046834MicroRNAs' role in the environment-related non-communicable diseases and link to multidrug resistance, regulation, or alteration.Environ Sci Pollut Res Int2021https://conductscience.org/library/papers/34046834PubMed
33802524Small Non-Coding-RNA in Gynecological Malignancies.Cancers (Basel)2021https://conductscience.org/library/papers/33802524PubMed
33133224circFAT1(e2) Promotes Papillary Thyroid Cancer Proliferation, Migration, and Invasion via the miRNA-873/ZEB1 Axis.Comput Math Methods Med2020https://conductscience.org/library/papers/33133224PubMed
32555352The tumor-suppressive role of microRNA-873 in nasopharyngeal carcinoma correlates with downregulation of ZIC2 and inhibition of AKT signaling pathway.Cancer Gene Ther2021https://conductscience.org/library/papers/32555352PubMed
32099406miR-873-5p Inhibits Cell Migration and Invasion of Papillary Thyroid Cancer via Regulation of CXCL16.Onco Targets Ther2020https://conductscience.org/library/papers/32099406PubMed
32010295MicroRNA-873 serves a critical role in human cervical cancer proliferation and metastasis via regulating glioma-associated oncogene homolog 1.Exp Ther Med2020https://conductscience.org/library/papers/32010295PubMed
31936634Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview.Cells2020https://conductscience.org/library/papers/31936634PubMed

See all 41 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
MIR873100126316PubTator's text mininghttps://conductscience.org/library/genes/100126316NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26850595

GET https://conductscience.org/api/papers/v1/26850595/references?page=2